Merck, Moderna claim 'promising' skin cancer vaccine results in key trial

2 months ago 5
U.S. pharmaceutical firms Merck and Moderna announced encouraging results Wednesday from a proceedings of their experimental vaccine against melanoma, perchance clearing the mode for approval.
Read Entire Article